Generic Name
NilotinibPacks Price
- Cap 150 mg(072543): 112: 360.369.03: 423.963.57
- Cap 150 mg(072543): 120: 386.109.68: 454.246.68
- Cap 150 mg(072543): 40: 96900.00: 114000.00
- Cap 200 mg(052256): 28: 90440.00: 106400.00
Nilotinib is a medication primarily indicated for the treatment of chronic myeloid leukemia (CML) in adults. Specifically, it is used for individuals with newly diagnosed CML in the chronic phase, as well as those with CML in the accelerated phase or blast crisis who are resistant or intolerant to other therapies. Nilotinib works by targeting specific proteins that contribute to the growth and proliferation of cancer cells, thereby helping to manage the progression of this type of leukemia.
Treatment Of Newly Diagnosed Chronic Myeloid Leukaemia in The Chronic Phase:
Treatment Of Chronic And Accelerated Phase Chronic Myeloid Leukaemia In Patients Who Have Resistance To Or intolerance Of Previous Therapy, Including Imatinib:
Positive Evidence Of Risk: Avoid
Author
Shahid Arif